RecruitingPhase 1Phase 2NCT05548452

Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease

Intestinal Microbiota Transplant in Alcohol-Associated Chronic Liver Disease and Cirrhosis: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Sponsor

Virginia Commonwealth University

Enrollment

80 participants

Start Date

Nov 21, 2022

Study Type

INTERVENTIONAL

Conditions

Cirrhosis Alcohol Use Disorder Liver Disease; Alcohol-Related

Summary

The purpose of this research study is to test the safety, tolerability, and effectiveness of the capsules that contain bacteria from healthy individuals when used to treat alcohol craving and drinking.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Intestinal Microbiota Transplant (IMT) Capsules and a drug called Placebo Capsules for people with alcohol use disorder, cirrhosis, and other related conditions. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.